Neumora Therapeutics Announces 2026 Pipeline Strategy Including KOASTAL-2 and -3 Joint Readout, Initiation of NMRA-215 Obesity Clinical Program, and Advancement of NMRA-511

Reuters · 5d ago

Please log in to view news